Literature DB >> 24882347

Lobular neoplasia.

Tari A King1, Jorge S Reis-Filho2.   

Abstract

Lobular neoplasia (LN) is characterized by a dysfunctional E-cadherin-catenin axis, and loss of E-cadherin plays a causative role in the typical morphology of LN cells. LN is both a nonobligate precursor and a risk indicator of invasive breast cancer, and in particular, of invasive lobular carcinoma. Despite the evidence supporting the precursor role of LN, its impact on clinical management has been a matter of controversy, and conservative management remains the mainstay of treatment. In this article, an update is provided on the pathology and genetics of LN, and the management of these lesions in surgical practice is discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical lobular hyperplasia; Breast cancer risk; Chemoprevention; E-cadherin; Lobular carcinoma in situ; Lobular neoplasia

Mesh:

Substances:

Year:  2014        PMID: 24882347     DOI: 10.1016/j.soc.2014.03.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  6 in total

1.  Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.

Authors:  Faina Nakhlis; Fisher D Katlin; Samantha C Grossmith; Ashley DiPasquale; Beth T Harrison; Stuart J Schnitt; Tari A King
Journal:  Ann Surg Oncol       Date:  2022-06-30       Impact factor: 4.339

2.  Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast.

Authors:  Constanze Elfgen; Christoph Tausch; Ann-Katrin Rodewald; Uwe Güth; Christoph Rageth; Vesna Bjelic-Radisic; Markus Fleisch; Claudia Kurtz; Jesus Gonzalez Diaz; Zsuzsanna Varga
Journal:  Breast Care (Basel)       Date:  2021-07-07       Impact factor: 2.268

3.  Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer.

Authors:  Eleni Kalogera; Constantinos Pistos; Xeni Provatopoulou; Costas A Christophi; George C Zografos; Maria Stefanidou; Chara Spiliopoulou; Sotirios Athanaselis; Antonia Gounaris
Journal:  J Chromatogr Sci       Date:  2016-01-12       Impact factor: 1.618

4.  Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.

Authors:  Bruno Cutuli; Brigitte De Lafontan; Youlia Kirova; Hugues Auvray; Agnes Tallet; Sandrine Avigdor; Claire Brunaud; Catherine Delva
Journal:  Radiat Oncol       Date:  2015-05-06       Impact factor: 3.481

Review 5.  Molecular drivers of lobular carcinoma in situ.

Authors:  Greg J Logan; David J Dabbs; Peter C Lucas; Rachel C Jankowitz; Daniel D Brown; Beth Z Clark; Steffi Oesterreich; Priscilla F McAuliffe
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

6.  Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists.

Authors:  Linda Moskovszky; Barbara Berger; Achim Fleischmann; Thomas Friedrich; Birgit Helmchen; Meike Körner; Tilman T Rau; Zsuzsanna Varga
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-30       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.